|
Section 113.1
|
Testing aids |
|
Section 113.2
|
Sampling of biological products |
|
Section 113.3
|
Exemptions to tests |
|
Section 113.4
|
General testing |
|
Section 113.5
|
Animal and Plant Health Inspection Service testing |
|
Section 113.6
|
Multiple fractions |
|
Section 113.7
|
In vitro tests for serial release |
|
Section 113.8
|
New potency test |
|
Section 113.9
|
Testing of bulk material for export or for further manufacture |
|
Section 113.10
|
Culture media for detection of bacteria and fungi |
|
Section 113.25
|
Detection of viable bacteria and fungi except in live vaccine |
|
Section 113.26
|
Detection of extraneous viable bacteria and fungi in live vaccines |
|
Section 113.27
|
Detection of mycoplasma contamination |
|
Section 113.28
|
Determination of moisture content in desiccated biological products |
|
Section 113.29
|
Detection of Salmonella contamination |
|
Section 113.30
|
Detection of avian lymphoid leukosis |
|
Section 113.31
|
Detection of Brucella contamination |
|
Section 113.32
|
Mouse safety tests |
|
Section 113.33
|
Detection of hemagglutinating viruses |
|
Section 113.34
|
Detection of viricidal activity |
|
Section 113.35
|
Detection of pathogens by the chicken inoculation test |
|
Section 113.36
|
Detection of pathogens by the chicken embryo inoculation test |
|
Section 113.37
|
Guinea pig safety test |
|
Section 113.38
|
Cat safety tests |
|
Section 113.39
|
Dog safety tests |
|
Section 113.40
|
Calf safety test |
|
Section 113.41
|
Detection of lymphocytic choriomeningitis contamination |
|
Section 113.42
|
Detection of chlamydial agents |
|
Section 113.43
|
Swine safety test |
|
Section 113.44
|
Sheep safety test |
|
Section 113.45
|
Detection of cytopathogenic and/or hemadsorbing agents |
|
Section 113.46
|
Detection of extraneous viruses by the fluorescent antibody technique |
|
Section 113.47
|
Ingredients of biological products |
|
Section 113.50
|
Requirements for primary cells used for production of biologics |
|
Section 113.51
|
Requirements for cell lines used for production of biologics |
|
Section 113.52
|
Requirements for ingredients of animal origin used for production of biologics |
|
Section 113.53
|
Sterile diluent |
|
Section 113.54
|
Detection of extraneous agents in Master Seed Virus |
|
Section 113.55
|
General requirements for live bacterial vaccines |
|
Section 113.64
|
Brucella Abortus Vaccine |
|
Section 113.65
|
Anthrax Spore Vaccine--Nonencapsulated |
|
Section 113.66
|
Erysipelothrix Rhusiopathiae Vaccine |
|
Section 113.67
|
Pasteurella Haemolytica Vaccine, Bovine |
|
Section 113.68
|
Pasteurella Multocida Vaccine, Bovine |
|
Section 113.69
|
Pasteurella Multocida Vaccine, Avian Isolate |
|
Section 113.70
|
Chlamydia Psittaci Vaccine (Feline Pneumonitis), Live Chlamydia |
|
Section 113.71
|
General requirements for inactivated bacterial products |
|
Section 113.100
|
Leptospira Pomona Bacterin |
|
Section 113.101
|
Leptospira Icterohaemorrhagiae Bacterin |
|
Section 113.102
|
Leptospira Canicola Bacterin |
|
Section 113.103
|
Leptospira Grippotyphosa Bacterin |
|
Section 113.104
|
Leptospira Hardjo Bacterin |
|
Section 113.105
|
Clostridium Chauvoei Bacterin |
|
Section 113.106
|
Clostridium Haemolyticum Bacterin |
|
Section 113.107
|
Clostridium Novyi Bacterin-Toxoid |
|
Section 113.108
|
Clostridium Sordellii Bacterin-Toxoid |
|
Section 113.109
|
Clostridium Botulinum Type C Bacterin-Toxoid |
|
Section 113.110
|
Clostridium Perfringens Type C Toxoid and Bacterin-Toxoid |
|
Section 113.111
|
Clostridium Perfringens Type D Toxoid and Bacterin-Toxoid |
|
Section 113.112
|
Autogenous biologics |
|
Section 113.113
|
Tetanus Toxoid |
|
Section 113.114
|
Staphylococcus Aureus Bacterin-Toxoid |
|
Section 113.115
|
Pasteurella Multocida Bacterin, Avian Isolate, Type 4 |
|
Section 113.116
|
Pasteurella Multocida Bacterin, Avian Isolate, Type 1 |
|
Section 113.117
|
Pasteurella Multocida Bacterin, Avian Isolate, Type 3 |
|
Section 113.118
|
Erysipelothrix Rhusiopathiae Bacterin |
|
Section 113.119
|
Salmonella Typhimurium Bacterin |
|
Section 113.120
|
Pasteurella Multocida Bacterin |
|
Section 113.121
|
Salmonella Choleraesuis Bacterin |
|
Section 113.122
|
Salmonella Dublin Bacterin |
|
Section 113.123
|
General requirements for killed virus vaccines |
|
Section 113.200
|
Mink Enteritis Vaccine, Killed Virus |
|
Section 113.204
|
Newcastle Disease Vaccine, Killed Virus |
|
Section 113.205
|
Wart Vaccine, Killed Virus |
|
Section 113.206
|
Encephalomyelitis Vaccine, Eastern, Western, and Venezuelan, Killed Virus |
|
Section 113.207
|
Avian Encephalomyelitis Vaccine, Killed Virus |
|
Section 113.208
|
Rabies Vaccine, Killed Virus |
|
Section 113.209
|
Feline Calicivirus Vaccine, Killed Virus |
|
Section 113.210
|
Bursal Disease Vaccine, Killed Virus |
|
Section 113.212
|
Bovine Virus Diarrhea Vaccine, Killed Virus |
|
Section 113.215
|
Bovine Rhinotracheitis Vaccine, Killed Virus |
|
Section 113.216
|
General requirements for live virus vaccines |
|
Section 113.300
|
Ovine Ecthyma Vaccine |
|
Section 113.301
|
Distemper Vaccine--Mink |
|
Section 113.302
|
Bluetongue Vaccine |
|
Section 113.303
|
Feline Panleukopenia Vaccine |
|
Section 113.304
|
Canine Hepatitis and Canine Adenovirus Type 2 Vaccine |
|
Section 113.305
|
Canine Distemper Vaccine |
|
Section 113.306
|
Encephalomyelitis Vaccine, Venezuelan |
|
Section 113.308
|
Bovine Parainfluenza [bdi3] Vaccine |
|
Section 113.309
|
Bovine Rhinotracheitis Vaccine |
|
Section 113.310
|
Bovine Virus Diarrhea Vaccine |
|
Section 113.311
|
Rabies Vaccine, Live Virus |
|
Section 113.312
|
Measles Vaccine |
|
Section 113.313
|
Feline Calicivirus Vaccine |
|
Section 113.314
|
Feline Rhinotracheitis Vaccine |
|
Section 113.315
|
Canine Parainfluenza Vaccine |
|
Section 113.316
|
Parvovirus Vaccine (Canine) |
|
Section 113.317
|
Pseudorabies Vaccine |
|
Section 113.318
|
Avian Encephalomyelitis Vaccine |
|
Section 113.325
|
Avian Pox Vaccine |
|
Section 113.326
|
Bronchitis Vaccine |
|
Section 113.327
|
Fowl Laryngotracheitis Vaccine |
|
Section 113.328
|
Newcastle Disease Vaccine |
|
Section 113.329
|
Marek's Disease Vaccines |
|
Section 113.330
|
Bursal Disease Vaccine |
|
Section 113.331
|
Tenosynovitis Vaccine |
|
Section 113.332
|
Tuberculin, Intradermic |
|
Section 113.406
|
Pullorum antigen |
|
Section 113.407
|
Avian mycoplasma antigen |
|
Section 113.408
|
Tuberculin--PPD Bovis, Intradermic |
|
Section 113.409
|
General requirements for antibody products |
|
Section 113.450
|
Tetanus Antitoxin |
|
Section 113.451
|
Erysipelothrix Rhusiopathiae Antibody |
|
Section 113.452
|
Clostridium Perfringens Type C Antitoxin |
|
Section 113.454
|
Clostridium Perfringens Type D Antitoxin |
|
Section 113.455
|
Products for treatment of failure of passive transfer |
|
Section 113.499
|
Applicability |